drugset / Trial / NCT05932303

A Study to Assess the Effect of Multiple Doses of Itraconazole, Gemfibrozil, or Carbamazepine on BMS-986278 in Healthy Participants

NCT05932303

Phase 1 Completed 47 enrolled Bristol-Myers Squibb
Non-randomizedSequentialOpen-labelTreatment

Summary

This is a study in healthy participants designed to assess the effect of multiple doses of itraconazole, gemfibrozil, or carbamazepine on the drug levels of a single-dose of BMS-986278.

Timeline

Start
2023-07-12
Primary completion
2023-10-23
Completion
2023-10-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Admilparant Small molecule
Subject Carbamazepine Small molecule
Subject Gemfibrozil Small molecule
Subject Itraconazole Small molecule

Indications

No indication recorded.